Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
1.160
+0.020 (1.75%)
At close: Dec 12, 2025, 4:00 PM EST
1.150
-0.010 (-0.86%)
Pre-market: Dec 15, 2025, 7:05 AM EST
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $152.07 million as of December 15, 2025. Its market cap has increased by 174.72% in one year.
Market Cap
152.07M
Enterprise Value
128.03M
1-Year Change
174.72%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $152.07M, a decrease of -70.42%. That is a compound annual growth rate of -25.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 152.07M | 235.02% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
| Oct 14, 2021 | 514.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |